サンプル依頼リスト カート
  • English
  • Korean
  • Traditional Chinese
  • Simplified Chinese
市場調査レポート
商品コード
1463582

中南米の牛の診断薬：2030年市場予測-地域別分析-製品別、疾患タイプ別、エンドユーザー別

South & Central America Bovine Diagnostics Market Forecast to 2030 - Regional Analysis - by Product, Disease Type, and End User (Veterinary Hospitals, Veterinary Clinics, and Other End-Users)
出版日: | 発行: The Insight Partners | ページ情報: 英文 70 Pages | 納期: 即納可能 即納可能とは

価格
価格表記: USDを日本円(税抜)に換算
本日の銀行送金レート: 1USD=157.14円
中南米の牛の診断薬：2030年市場予測-地域別分析-製品別、疾患タイプ別、エンドユーザー別
出版日: 2024年01月19日
発行: The Insight Partners
ページ情報: 英文 70 Pages
納期: 即納可能 即納可能とは
  • 全表示
  • 概要
  • 図表
  • 目次
概要

中南米の牛の診断薬市場は、2022年の1億1,401万米ドルから2030年には1億7,957万米ドルに成長すると予測されています。2022～2030年のCAGRは5.8%と推定されます。

牛乳房炎の高い流行率と経済的影響が中南米の牛の診断薬市場を後押し

牛の乳房炎は、世界の農業セクターに莫大な経済的損失をもたらす世界の問題です。乳房炎は罹患動物の乳生産量の低下を招き、継続的な獣医療的出費の原因となるため、酪農業従事者の収益性を低下させます。Thermo Fisher Scientificが2022年7月に発表した推定によると、乳房炎による世界の酪農産業の年間総コストは197億～320億米ドルです。

2021年4月に発表された研究「Global and countrywide prevalence of subclinical and clinical mastitis in dairy cattle and buffaloes by systematic review and meta-analysis（乳牛と水牛における潜在性乳房炎と臨床性乳房炎の世界的と国全体の有病率：系統的レビューとメタ分析による）」によると、2011～2019年の間にプールされた潜在性乳房炎（SCM）と臨床性乳房炎（CM）の世界的有病率はそれぞれ42％と15％でした。乳房炎の有病率は、酪農産業における乳房炎の歴史が長いため、増加すると予想されます。世界中の事実とデータは、臨床的乳房炎の高い有病率を示しており、これが牛用診断薬の需要を誘発します。さらに、各国政府が導入しているサーベイランスプログラムや適正管理システムが牛の診断薬市場を支えています。

中南米の牛の診断薬市場概要

中南米の牛の診断薬市場は、ブラジル、アルゼンチン、その他の南米に区分されます。この地域の市場成長は、主に牛診断ツールや技術の進歩、口蹄疫や結核菌の増加、牛肉を含む食品の品質向上のための牛診断の増加といった要因によってもたらされます。ブラジルは中南米における牛の診断薬市場の最大シェアを占めています。ブラジルは世界一の畜産国であり、牛の飼育頭数も世界一です。世界人口の増加と生活水準の向上は、世界中で食肉需要を押し上げています。そのため、健康な肉への需要がブラジルの牛の診断薬市場の成長をもたらしています。診断技術の進歩により、牛白血病ウイルス（BLV）の診断と系統解析が可能になりました。乳牛のBLV感染はブラジル北東部のMaranhaoで顕著であり、2022年に初めて、系統学的な推論によりこの地域で遺伝子型6が示されました。この遺伝子型は、以前にブラジル中西部と南東部のサンプルで同定された遺伝子配列と関連しています。このように、BLVとEBL診断のための開発努力が2022年に開始されたことで、早期段階にある感染症例に対する白血病治療の選択肢の進展が促進されました。発病牛白血病（EBL）は牛群に広く分布する慢性ウイルス性疾患で、臨床症状が現れるまでに数年かかることがあります。したがって、牛の流行を防ぐためには、診断によって獣医保健当局や畜産農業従事者が事前の対策を講じることができます。

中南米の牛の診断薬市場の収益と2030年までの予測（金額）

中南米の牛の診断薬市場セグメンテーション

中南米の牛の診断薬市場は、製品、疾患タイプ、エンドユーザー、国に区分されます。

製品別では、中南米の牛の診断薬市場はイムノアッセイキット、PCR試薬＆キット、血球凝集阻害（HI）アッセイ、その他製品に区分されます。2022年の中南米牛の診断薬市場では、イムノアッセイキット部門が最大のシェアを占めています。

疾病タイプ別に見ると、中南米の牛の診断薬市場は牛ウイルス性下痢（BVD）、牛結核（TB）、牛乳房炎、口蹄疫（FMD）、その他の疾病タイプに区分されます。2022年の中南米牛の診断薬市場では、牛乳房炎セグメントが最大シェアを占めました。

エンドユーザー別に見ると、中南米の牛の診断薬市場は動物病院、動物クリニック、その他のエンドユーザーに区分されます。2022年の中南米の牛の診断薬市場では、動物病院セグメントが最大のシェアを占めています。

国別に見ると、中南米の牛の診断薬市場はブラジル、アルゼンチン、その他の南米に区分されます。2022年の中南米牛の診断薬市場はブラジルが独占。

Idexx Laboratories Inc、bioMerieux SA、Innovative Diagnostics SAS、Neogen Corp、Thermo Fisher Scientific Incなどが中南米の牛の診断薬市場で事業を展開する大手企業です。

目次

第1章 イントロダクション

第2章 エグゼクティブサマリー

第3章 調査手法

  • 対象範囲
  • 2次調査
  • 1次調査

第4章 中南米の牛の診断薬市場：主要産業力学

  • 主要市場の促進要因
    • 牛乳房炎の高い有病率と経済的影響
    • 製品上市数の増加
  • 主要市場抑制要因
    • 獣医療研究における熟練専門家の不足
  • 主要市場機会
    • 牛結核の高い有病率
  • 今後の動向
    • データ分析と人工知能（AI）の統合
  • 影響分析

第5章 牛の診断薬市場：中南米市場分析

  • 中南米の牛の診断薬市場収益、2022～2030年

第6章 中南米牛の診断薬市場：2030年までの収益と予測：製品別

  • イントロダクション
  • 中南米牛の診断薬市場：2022年と2030年、製品別売上高シェア（%）
  • 免疫測定キット
  • PCRキット
  • 血球凝集阻害（HI）アッセイ
  • その他

第7章 中南米牛の診断薬市場：2030年までの収益と予測：疾病タイプ別

  • イントロダクション
  • 中南米牛の診断薬市場：2022年と2030年、疾患タイプ別売上高シェア（%）
  • 牛ウイルス性下痢症（BVD）
  • 牛結核（TB）
  • 牛乳房炎
  • 口蹄疫（FMD）
  • その他の疾病

第8章 中南米牛の診断薬市場：2030年までの収益と予測：エンドユーザー別

  • イントロダクション
  • 中南米牛の診断薬市場：2022年と2030年、エンドユーザー別売上高シェア（%）
  • 動物病院
  • 動物クリニック
  • その他

第9章 中南米の牛の診断薬市場：国別分析

  • ブラジル
  • アルゼンチン
  • その他の中南米

第10章 牛の診断薬市場：業界情勢

  • イントロダクション
  • 成長戦略

第11章 企業プロファイル

  • Idexx Laboratories Inc
  • Thermo Fisher Scientific Inc
  • Innovative Diagnostics SAS
  • Neogen Corp
  • bioMerieux SA

第12章 付録

図表

List Of Tables

  • Table 1. South & Central America Bovine Diagnostics Market Segmentation
  • Table 2. Brazil: South & Central America Bovine Diagnostics Market Revenue and Forecast to 2030 (US$ Mn) - Product
  • Table 3. Brazil: South & Central America Bovine Diagnostics Market Revenue and Forecast to 2030 (US$ Mn) - Disease Type
  • Table 4. Brazil: South & Central America Bovine Diagnostics Market Revenue and Forecast to 2030 (US$ Mn) - End User
  • Table 5. Argentina: South & Central America Bovine Diagnostics Market Revenue and Forecast to 2030 (US$ Mn) - Product
  • Table 6. Argentina: South & Central America Bovine Diagnostics Market Revenue and Forecast to 2030 (US$ Mn) - Disease Type
  • Table 7. Argentina: South & Central America Bovine Diagnostics Market Revenue and Forecast to 2030 (US$ Mn) - End User
  • Table 8. Rest of South & Central America: South & Central America Bovine Diagnostics Market Revenue and Forecast to 2030 (US$ Mn) - Product
  • Table 9. Rest of South & Central America: South & Central America Bovine Diagnostics Market Revenue and Forecast to 2030 (US$ Mn) - Disease Type
  • Table 10. Rest of South & Central America: South & Central America Bovine Diagnostics Market Revenue and Forecast to 2030 (US$ Mn) - End User
  • Table 11. Recent Growth Strategies in Bovine Diagnostics Market
  • Table 12. Glossary of Terms, South & Central America Bovine Diagnostics Market

List Of Figures

  • Figure 1. South & Central America Bovine Diagnostics Market Segmentation, By Country
  • Figure 2. Key Insights
  • Figure 3. Market Attractiveness
  • Figure 4. South & Central America Bovine Diagnostics Market - Key Industry Dynamics
  • Figure 5. Impact Analysis of Drivers and Restraints
  • Figure 6. South & Central America Bovine Diagnostics Market Revenue (US$ Mn), 2022 - 2030
  • Figure 7. South & Central America Bovine Diagnostics Market Revenue Share, by Product 2022 & 2030 (%)
  • Figure 8. Immunoassay Kits: South & Central America Bovine Diagnostics Market - Revenue and Forecast to 2030 (US$ Million)
  • Figure 9. PCR Kits: South & Central America Bovine Diagnostics Market - Revenue and Forecast to 2030 (US$ Million)
  • Figure 10. Hemagglutination Inhibition (HI) Assay: South & Central America Bovine Diagnostics Market - Revenue and Forecast to 2030 (US$ Million)
  • Figure 11. Other Products: South & Central America Bovine Diagnostics Market - Revenue and Forecast to 2030 (US$ Million)
  • Figure 12. South & Central America Bovine Diagnostics Market Revenue Share, by Disease Type 2022 & 2030 (%)
  • Figure 13. Bovine Viral Diarrhea (BVD): South & Central America Bovine Diagnostics Market - Revenue and Forecast to 2030 (US$ Million)
  • Figure 14. Bovine Tuberculosis (TB): South & Central America Bovine Diagnostics Market - Revenue and Forecast to 2030 (US$ Million)
  • Figure 15. Bovine Mastitis: South & Central America Bovine Diagnostics Market - Revenue and Forecast to 2030 (US$ Million)
  • Figure 16. Foot and Mouth Disease (FMD): South & Central America Bovine Diagnostics Market - Revenue and Forecast to 2030 (US$ Million)
  • Figure 17. Other Disease Types: South & Central America Bovine Diagnostics Market - Revenue and Forecast to 2030 (US$ Million)
  • Figure 18. South & Central America Bovine Diagnostics Market Revenue Share, by end user 2022 & 2030 (%)
  • Figure 19. Veterinary Hospitals: South & Central America Bovine Diagnostics Market - Revenue and Forecast to 2030 (US$ Million)
  • Figure 20. Veterinary Clinics: South & Central America Bovine Diagnostics Market - Revenue and Forecast to 2030 (US$ Million)
  • Figure 21. Other End-Users: South & Central America Bovine Diagnostics Market - Revenue and Forecast to 2030 (US$ Million)
  • Figure 22. South & Central America Bovine Diagnostics Market, By Geography, 2022 ($Mn)
  • Figure 23. South & Central America Bovine Diagnostics Market, By Key Countries, 2022 And 2030 (%)
  • Figure 24. Brazil: South & Central America Bovine Diagnostics Market Revenue and Forecast to 2030 (US$ Mn)
  • Figure 25. Argentina: South & Central America Bovine Diagnostics Market Revenue and Forecast to 2030 (US$ Mn)
  • Figure 26. Rest of South & Central America: South & Central America Bovine Diagnostics Market Revenue and Forecast to 2030 (US$ Mn)
目次
Product Code: BMIRE00029335

The South & Central America bovine diagnostics market is expected to grow from US$ 114.01 million in 2022 to US$ 179.57 million by 2030. It is estimated to grow at a CAGR of 5.8% from 2022 to 2030.

High Prevalence and Economic Impact of Bovine Mastitis Fuels South & Central America Bovine Diagnostics Market

Bovine mastitis is a global concern that incurs huge economic losses to the global agriculture sector. Mastitis results in lowered milk production in affected animals and causes continuous veterinary expenses, resulting in reduced profitability for dairy farmers. According to the estimates published by Thermo Fisher Scientific in July 2022, the total annual cost to the global dairy industry caused by mastitis is between US$ 19.7 billion to US$ 32 billion.

According to the study "Global and countrywide prevalence of subclinical and clinical mastitis in dairy cattle and buffaloes by systematic review and meta-analysis," published in April 2021, the global pooled prevalence of subclinical mastitis (SCM) and clinical mastitis (CM) were 42% and 15%, respectively, during 2011-2019. The prevalence of mastitis is expected to increase due to the prolonged history of the disease in the dairy industry. The facts and data from across the world indicate the high prevalence of clinical mastitis, which triggers the demand for bovine diagnostics. Moreover, surveillance programs and good management systems introduced by governments in different countries support the bovine diagnostics market.

South & Central America Bovine Diagnostics Market Overview

The bovine diagnostics market in South & Central America is segmented into Brazil, Argentina, and the Rest of South & Central America. The market growth in this region is mainly driven by the factors such as advancements in bovine diagnostics tools and technologies, increasing incidences of foot and mouth diseases and bTB, and a rise in bovine diagnostics to enhance the quality of food products containing bovine meat. Brazil counts for the largest share of the bovine diagnostic market in South & Central America. Brazil is the world's leading livestock country, with the largest number of cattle grown. The growth of the world's population and improvements in living standards boost the demand for meat across the world. Therefore, the demand for healthy meats results in the growth of the bovine diagnostics market in Brazil. Technological progress in diagnostics has enabled the diagnosis and phylogenetic analysis of bovine leukemia virus (BLV). The BLV infection in dairy cattle was evident in Maranhao, Northeastern Brazil, and for the first time in 2022, phylogenetic inferences showed genotype 6 in this region. This genotype is related to gene sequences previously identified in samples from central-western and southeastern Brazil. Thus, the development efforts for BLV and EBL diagnosis were initiated in 2022, which has fueled progress in leukemia treatment options for the cases of infections that are in an early stage. Enzootic bovine leukosis (EBL) is a chronic viral disease widely distributed in cattle herds and may take several years to manifest clinical signs. Thus, to prevent the epidemic in cattle, the diagnosis would allow veterinary health authorities and animal farmers to take preliminary actions.

South & Central America Bovine Diagnostics Market Revenue and Forecast to 2030 (US$ Million)

South & Central America Bovine Diagnostics Market Segmentation

The South & Central America bovine diagnostics market is segmented into product, disease type, end user, and country.

Based on product, the South & Central America bovine diagnostics market is segmented into immunoassay kits, PCR reagents & kits, hemagglutination inhibition (HI) assay, and other products. The immunoassay kits segment held the largest share of the South & Central America bovine diagnostics market in 2022.

Based on disease type, the South & Central America bovine diagnostics market is segmented into bovine viral diarrhea (BVD), bovine tuberculosis (TB), bovine mastitis, foot and mouth disease (FMD), and other disease types. The bovine mastitis segment held the largest share of the South & Central America bovine diagnostics market in 2022.

Based on end user, the South & Central America bovine diagnostics market is segmented into veterinary hospitals, veterinary clinics, and other end-users. The veterinary hospitals segment held the largest share of the South & Central America bovine diagnostics market in 2022.

Based on country, the South & Central America bovine diagnostics market is segmented int o Brazil, Argentina, and the Rest of South & Central America. Brazil dominated the South & Central America bovine diagnostics market in 2022.

Idexx Laboratories Inc, bioMerieux SA, Innovative Diagnostics SAS, Neogen Corp, and Thermo Fisher Scientific Inc are some of the leading companies operating in the South & Central America bovine diagnostics market.

Table Of Contents

1. Introduction

  • 1.1 The Insight Partners Research Report Guidance
  • 1.2 Market Segmentation

2. Executive Summary

3. Research Methodology

  • 3.1 Coverage
  • 3.2 Secondary Research
  • 3.3 Primary Research

4. South & Central America Bovine Diagnostics Market - Key Industry Dynamics

  • 4.1 Key Market Drivers:
    • 4.1.1 High Prevalence and Economic Impact of Bovine Mastitis
    • 4.1.2 Increasing Number of Product Launches
  • 4.2 Key Market Restraints:
    • 4.2.1 Lack of Skilled Professionals in Veterinary Research
  • 4.3 Key Market Opportunities:
    • 4.3.1 High Prevalence of Bovine Tuberculosis
  • 4.4 Future Trends
    • 4.4.1 Integration of Data Analytics and Artificial Intelligence (AI)
  • 4.5 Impact Analysis:

5. Bovine Diagnostics Market - South & Central America Market Analysis

  • 5.1 South & Central America Bovine Diagnostics Market Revenue (US$ Mn), 2022 - 2030

6. South & Central America Bovine Diagnostics Market - Revenue and Forecast to 2030 - by Product

  • 6.1 Overview
  • 6.2 South & Central America Bovine Diagnostics Market Revenue Share, by Product 2022 & 2030 (%)
  • 6.3 Immunoassay Kits
    • 6.3.1 Overview
    • 6.3.2 Immunoassay Kits: South & Central America Bovine Diagnostics Market - Revenue and Forecast to 2030 (US$ Million)
  • 6.4 PCR Kits
    • 6.4.1 Overview
    • 6.4.2 PCR Kits: South & Central America Bovine Diagnostics Market - Revenue and Forecast to 2030 (US$ Million)
  • 6.5 Hemagglutination Inhibition (HI) Assay
    • 6.5.1 Overview
    • 6.5.2 Hemagglutination Inhibition (HI) Assay: South & Central America Bovine Diagnostics Market - Revenue and Forecast to 2030 (US$ Million)
  • 6.6 Other Products
    • 6.6.1 Overview
    • 6.6.2 Other Products: South & Central America Bovine Diagnostics Market - Revenue and Forecast to 2030 (US$ Million)

7. South & Central America Bovine Diagnostics Market - Revenue and Forecast to 2030 - by Disease Type

  • 7.1 Overview
  • 7.2 South & Central America Bovine Diagnostics Market Revenue Share, by Disease Type 2022 & 2030 (%)
  • 7.3 Bovine Viral Diarrhea (BVD)
    • 7.3.1 Overview
    • 7.3.2 Bovine Viral Diarrhea (BVD): South & Central America Bovine Diagnostics Market - Revenue and Forecast to 2030 (US$ Million)
  • 7.4 Bovine Tuberculosis (TB)
    • 7.4.1 Overview
    • 7.4.2 Bovine Tuberculosis (TB): South & Central America Bovine Diagnostics Market - Revenue and Forecast to 2030 (US$ Million)
  • 7.5 Bovine Mastitis
    • 7.5.1 Overview
    • 7.5.2 Bovine Mastitis: South & Central America Bovine Diagnostics Market - Revenue and Forecast to 2030 (US$ Million)
  • 7.6 Foot and Mouth Disease (FMD)
    • 7.6.1 Overview
    • 7.6.2 Foot and Mouth Disease (FMD): South & Central America Bovine Diagnostics Market - Revenue and Forecast to 2030 (US$ Million)
  • 7.7 Other Disease Types
    • 7.7.1 Overview
    • 7.7.2 Other Disease Types: South & Central America Bovine Diagnostics Market - Revenue and Forecast to 2030 (US$ Million)

8. South & Central America Bovine Diagnostics Market - Revenue and Forecast to 2030 - by End User

  • 8.1 Overview
  • 8.2 South & Central America Bovine Diagnostics Market Revenue Share, by end user 2022 & 2030 (%)
  • 8.3 Veterinary Hospitals
    • 8.3.1 Overview
    • 8.3.2 Veterinary Hospitals: South & Central America Bovine Diagnostics Market - Revenue and Forecast to 2030 (US$ Million)
  • 8.4 Veterinary Clinics
    • 8.4.1 Overview
    • 8.4.2 Veterinary Clinics: South & Central America Bovine Diagnostics Market - Revenue and Forecast to 2030 (US$ Million)
  • 8.5 Other End-Users
    • 8.5.1 Overview
    • 8.5.2 Other End-Users: South & Central America Bovine Diagnostics Market - Revenue and Forecast to 2030 (US$ Million)

9. South & Central America Bovine Diagnostics Market - Country Analysis

  • 9.1 South & Central America Bovine Diagnostics Market, Revenue and Forecast to 2030
    • 9.1.1 Overview
      • 9.1.1.1 South & Central America Bovine Diagnostics Market, by Country
      • 9.1.1.2 Brazil
        • 9.1.1.2.1 Overview
        • 9.1.1.2.2 Brazil: South & Central America Bovine Diagnostics Market Revenue and Forecast to 2030 (US$ Mn)
        • 9.1.1.2.3 Brazil: South & Central America Bovine Diagnostics Market, by Product
        • 9.1.1.2.4 Brazil: South & Central America Bovine Diagnostics Market, by Disease Type
        • 9.1.1.2.5 Brazil: South & Central America Bovine Diagnostics Market, by End User
      • 9.1.1.3 Argentina
        • 9.1.1.3.1 Overview
        • 9.1.1.3.2 Argentina: South & Central America Bovine Diagnostics Market Revenue and Forecast to 2030 (US$ Mn)
        • 9.1.1.3.3 Argentina: South & Central America Bovine Diagnostics Market, by Product
        • 9.1.1.3.4 Argentina: South & Central America Bovine Diagnostics Market, by Disease Type
        • 9.1.1.3.5 Argentina: South & Central America Bovine Diagnostics Market, by End User
      • 9.1.1.4 Rest of South & Central America
        • 9.1.1.4.1 Overview
        • 9.1.1.4.2 Rest of South & Central America: South & Central America Bovine Diagnostics Market Revenue and Forecast to 2030 (US$ Mn)
        • 9.1.1.4.3 Rest of South & Central America: South & Central America Bovine Diagnostics Market, by Product
        • 9.1.1.4.4 Rest of South & Central America: South & Central America Bovine Diagnostics Market, by Disease Type
        • 9.1.1.4.5 Rest of South & Central America: South & Central America Bovine Diagnostics Market, by End User

10. Bovine Diagnostics Market - Industry Landscape

  • 10.1 Overview
  • 10.2 Growth Strategies
    • 10.2.1 Overview

11. Company Profiles

  • 11.1 Idexx Laboratories Inc
    • 11.1.1 Key Facts
    • 11.1.2 Business Description
    • 11.1.3 Products and Services
    • 11.1.4 Financial Overview
    • 11.1.5 SWOT Analysis
    • 11.1.6 Key Developments
  • 11.2 Thermo Fisher Scientific Inc
    • 11.2.1 Key Facts
    • 11.2.2 Business Description
    • 11.2.3 Products and Services
    • 11.2.4 Financial Overview
    • 11.2.5 SWOT Analysis
    • 11.2.6 Key Developments
  • 11.3 Innovative Diagnostics SAS
    • 11.3.1 Key Facts
    • 11.3.2 Business Description
    • 11.3.3 Products and Services
    • 11.3.4 Financial Overview
    • 11.3.5 SWOT Analysis
    • 11.3.6 Key Developments
  • 11.4 Neogen Corp
    • 11.4.1 Key Facts
    • 11.4.2 Business Description
    • 11.4.3 Products and Services
    • 11.4.4 Financial Overview
    • 11.4.5 SWOT Analysis
    • 11.4.6 Key Developments
  • 11.5 bioMerieux SA
    • 11.5.1 Key Facts
    • 11.5.2 Business Description
    • 11.5.3 Products and Services
    • 11.5.4 Financial Overview
    • 11.5.5 SWOT Analysis
    • 11.5.6 Key Developments

12. Appendix

  • 12.1 About Us
  • 12.2 Glossary of Terms